Akram, Asha <br/><br/>
Neuroprotection mediated by the EP₄ receptor avoids the detrimental side effects of COX-2 inhibitors following ischaemic injury.  [electronic resource] 

 -  Neuropharmacology  Feb 2013 
 - 165-72 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1873-7064 
<br/><br/><label>Standard No.: </label>10.1016/j.neuropharm.2012.09.010  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Brain Ischemia--pathology<br/>Cyclooxygenase 2 Inhibitors--pharmacology<br/>Hippocampus--drug effects<br/>Isoindoles--pharmacology<br/>Male<br/>Mice<br/>Mice, Inbred C57BL<br/>Neuroprotective Agents--pharmacology<br/>Organ Culture Techniques<br/>Random Allocation<br/>Receptors, Prostaglandin E, EP4 Subtype--agonists<br/>Sulfonamides--pharmacology